Co existence of ampc and extended spectrum beta lactamases resistance in metallo beta lactamases producing strains of pseudomonas aeruginosa

International Journal of Pharma and Bio Sciences

Volumn 5, Issue 3, 2014, Pages

  Mishra, Vikas ^a   Gupta, Pratima ^b   Kakati, Barnali ^c  

^a Rama Dental College Hospital and Research Center   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c HIMALAYAN INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

AmpC; ESBL; Metallo beta lactamases; P.aeruginosa

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAMASE AMPC; CEFEPIME; CEFOPERAZONE PLUS SULBACTAM; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; COLISTIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

AMPC DISK TEST; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; DISC POTENTIATION TEST; ENZYME SYNTHESIS; EPSILOMETER TEST; INCIDENCE; INFECTION CONTROL; METALLO BETA LACTAMASE PRODUCING PSEUDOMONAS AERUGINOSA; MODIFIED HODGE TEST; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; RISK FACTOR;

EID: 84904870446     PISSN: None     EISSN: 09756299     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. th ed. New York: Mc Graw Hill; 2008: p. 949-56
2. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992 to June 2003. Am J Infect Control. 2003; 31: 481-98
3. Mendiratta DK, Deotale V, Narang P. Metallo beta lactamase producing Pseudomonas aeruginosa in a hospital from rural area. Ind J Med Res. 2005; 121: 701-3
4. Varaiya A, Kulkarni M, Bhalekar P, Dogra J. Incidence of metallo-beta-lactamase producing Pseudomonas aeruginosa in diabetes and cancer patients. Indian J Patho Microbiol. 2008; 51: 200-3
5. Collee JG, Miles RS, Watt B. Tests for identification of bacteria. In collee JG, Fraser AG, Marmion BP, Simmons A, editors. Mackie and McCartney practical medical Microbiology. 14th ed. New York: Churchill Livingstone; 2007: p. 131-149
6. th ed. New York: Churchill Livingstone; 2008: p. 151-78
7. Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modified Hodge and EDTAdisk synergy tests to screen metallo beta lactamase producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect. 2001; 7: 88-91
8. Bashir D, Thokar MA, Fomda MA, Bashir G, Zahoor D, Ahmad S et al. Detection of metallo-beta-lactamase (MBL) producing Pseudomonas aeruginosa at a tertiary care hospital in Kashmir. Afr J Microbiol Res. 2011; 5(2): 164-72
9. CLSI: Perfomance Standards for antimicrobial disc susceptibility tests. CLSI:Wayne PA; 2005-p. M100-S15
10. Noyal MJC, Menezes GA, Harish BN, Sujatha S, Parija SC. Simple screening tests for detection of carbapenemase in clinical isolates of nonfermentative Gramnegative bacteria. Indian J Med Res. 2009; 129: 707-12
11. Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in P. aeruginosa. Antimicrob Agents Chemother. 1989; 35: 147-51
12. Yano H, Kuga A, Okamota R, Kitasato H, Kobayashi T, Inon M. Plasmid coded metallo beta lactamase (imp 6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother. 2001; 45: 1343-8
13. Navneeth BV, Sridaran D, Sahay D, Belwadi MR. A preliminary study on metallo beta lactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med Res 2002; 116: 264-7
14. Agarwal G, Lodhi RB, Kamalakar UP, Khadse RK, Jalgaonkar SV. Study of metallo-beta-lactamase production in clinical isolates of Pseudomonas aeruginosa. Indian J Med Microbiol. 2008; 26(4): 349-351
15. Jesudason MV, Kandathil A.J., Balaji V. Comparison of two methods to detect carbapenemase & metallo-β- lactamase production in clinical isolates. Indian J Med Res 2005; 121: 780-783
16. Khakhkhar VM, Thangjam RC, Bhuva PJ, Ballal M. Detection of Metallo-β-Lactamase Enzymes producing Pseudomonas aeruginosa. NJIRM. 2012; 3(4): 4-9
17. De AS, Kumar SH, Baveja SM. Prevalence of Metallo-β-Lactamase producing Producing Pseudomonas aeruginosa and Acinetobacter species in intensive care areas in a tertiary care hospital. Ind Journ of Crit Care Med. 2010; 14: 217-19
18. Sugino Y, Iinuma Y, Nada T, Tawada Y, Amano H, Nakamura T et al. Antimicrobial activities and mechanism of carbapenem resistance in clinical isolates of carbapenem resistant P. aeruginosa and Acinetobacter spp. J Jpn Assoc Infect Dis. 2001; 75: 662-70
19. Arakawa Y, Shibata N, Shibayama K. Convenient test for screening metallobeta-lactamase-producing gram-negative bacteria by using thiol compounds. J Clin Microbiol. 2000; 38 (1): 40-3
20. Yong D, Lee K, Yum JH. Imipenem-EDTA disk method for differentiation of metallobeta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol. 2002; 40 (10): 3798
21. Yan JJ, Wu JJ, Tsai SH, Chuang CL. Comparison of the double-disk, combined disk, and E test methods for detecting metallo-beta-lactamases in gram-negative bacilli. Diagn Microbiol Inf Dis. 2004; 49 (1): 5-11
22. Marchiaro P, Mussi MA, Ballerini V, Pasteran F, Viale AM, Vila AJ, et al. Sensitive EDTA-based microbiological assays for detection of metallo-β-lactamases in nonfermentative gramnegative bacteria. J Clin Microbiol. 2005; 43: 5648-52
23. Pitout JD, Gregson DB, Poirel L, McClure JA, Le P, Church DL. Detection of Pseudomonas aeruginosa producing metallo-β-lactamases in a large centralized laboratory. J Clin Microbiol. 2005; 43: 3129-3135
24. Behera B, Mathur P, Das A, Kapil A, Sharma V. An evaluation of four different phenotypic techniques for detection of metallo-β-lactamase producingPseudomonas aeruginosa. Indian J Med Microbiol. 2008; 26(3): 233-237
25. Manoharan A, chatterjee S, Mathai D. Detection and characterization of Metallo beta lactamases producing Pseudomonas aeruginosa. Indian J Med Microbiol. 2010; 28(3): 241-4
26. Anuradha SD, Kumar SH, Baveja SM. Prevalence of metallo-β-lactamase producing Pseudomonas aeruginosa and Acinetobacter species in intensive care areas in a tertiary care hospital. Indian Journal of Critical Care Medicine. 2010; 14(4): 217-19
27. Prajapati SB, Vegad MM, Mehta SJ, Kikani KM, Kamothi MN, Pandya JM. An evaluation of two different phenotypic methods for detection of metallo- β-lactamase producing Pseudomonas isolates. J. Cell and Tissue Research. 2011; 11(1): 2601-4
28. Yan JJ, Hsueh PR, Ko WC, Luh KT, Tsai SH, Wu HM, Wu JJ. Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrob. Agents Chemother. 2001; 45: 2224-28
29. Hirakata Y, Yamaguchi T, Nakano M, Izumikawa K, Mine M, Aoki S. Clinical and bacteriological characteristics of IMP-type metallo-beta-lactamase producing Pseudomonas aeruginosa. Clin Infect Dis. 2003; 37: 26-32
30. Falagas ME, Rizos M, Bliziotis IA. Toxicity after prolonged (more than four weeks) administration of intravenous Colistin. BMC Infect Dis. 2005; 5 (1): 1
31. Upadhyay S, Sen MR, Bhattacharjee A. Presence of different beta-lactamase classes among clinical isolates of Pseudomonas aeruginosa expressing AmpC beta-lactamase enzyme. J Infect Dev Ctries. 2010; 4(4): 239